Corient Private Wealth’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Buy |
78,935
+33,805
| +75% | +$567K | ﹤0.01% | 1289 |
|
|
2025
Q1 | $694K | Sell |
45,130
-11,720
| -21% | -$180K | ﹤0.01% | 1442 |
|
|
2024
Q4 | $1.25M | Sell |
56,850
-11,425
| -17% | -$252K | ﹤0.01% | 1214 |
|
|
2024
Q3 | $1.23M | Sell |
68,275
-21,458
| -24% | -$387K | ﹤0.01% | 1281 |
|
|
2024
Q2 | $1.46M | Buy |
89,733
+34,983
| +64% | +$568K | ﹤0.01% | 1170 |
|
|
2024
Q1 | $773K | Sell |
54,750
-69,086
| -56% | -$975K | ﹤0.01% | 1419 |
|
|
2023
Q4 | $1.29M | Sell |
123,836
-2,499
| -2% | -$26.1K | ﹤0.01% | 1186 |
|
|
2023
Q3 | $1.29M | Buy |
126,335
+56,683
| +81% | +$578K | ﹤0.01% | 1101 |
|
|
2023
Q2 | $524K | Sell |
69,652
-19,813
| -22% | -$149K | ﹤0.01% | 1426 |
|
|
2023
Q1 | $792K | Buy |
89,465
+19,500
| +28% | +$173K | ﹤0.01% | 1178 |
|
|
2022
Q4 | $638K | Buy |
+69,965
| New | +$638K | ﹤0.01% | 1060 |
|